Sign in

BMJ Medicine

@bmjmedicine.bsky.social
810 followers 304 following 214 posts

An #openaccess journal from #TheBMJ for specialist research that promotes multidisciplinary collaboration to improve the health of patients

PostsRepliesMedia
BMJ Medicine @bmjmedicine.bsky.social · 8h
A NEW cohort and data profile from Jonathan Emberson and colleagues provides an update of the Mexico City Prospective Study, one of the longest and largest population based studies of a Latin American population. Read now in BMJ Medicine: bit.ly/4ysg6GD
000
BMJ Medicine @bmjmedicine.bsky.social · 05/10/2026
As part of the NEW cohort and data profile series in BMJ Medicine, Michaela Benzeval and Meena Kumari provide a profile of the UK Household Longitudinal study bit.ly/4huXaQj
010
BMJ Medicine @bmjmedicine.bsky.social · 02/10/2026
📢 BMJ Medicine has a new cohort and data profiles series! These articles aim to help researchers identify reliable, trusted, and accessible sources of data for research. Find out more in the new editorial by Tom Nolan and colleagues: bit.ly/3VVmTds
030
BMJ Medicine @bmjmedicine.bsky.social · 30/09/2026
📢Introducing cohort and data profiles, a new article series from BMJ Medicine The series launches with 3 profiles: the UK Household Longitudinal Study, and updates to the Millennium Cohort Study and the Mexico City Prospective Study. Find all 3 profiles here in BMJ Medicine: bit.ly/4xSyojh
111
BMJ Medicine @bmjmedicine.bsky.social · 12/09/2026
New research from Padmini Selvaganesan and colleagues evaluates the effectiveness of SGLT2 inhibitors in reducing the risk of hospital admission for heart failure and mortality in patients with heart failure with preserved ejection fraction bit.ly/4gQXE30
011
BMJ Medicine @bmjmedicine.bsky.social · 10/09/2026
An intervention may be effective after a month, but not after a year - or vice verca. Belavý et al. used a time course network meta analysis study design to examine outcomes for conservative treatments for chronic non-specific lower back pain at different intervals.
140
BMJ Medicine @bmjmedicine.bsky.social · 08/09/2026
Deshi Chen and colleagues compare the efficacy and safety of GLP-1 based treatments for weight loss in non-diabetic adults with overweight or obesity, finding weight loss was greater with next generation incretin based treatments than conventional GLP-1 receptor agonists bit.ly/4zPl2X8
bit.ly
Comparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trials
Objective To compare the efficacy and safety of glucagon-like peptide 1 (GLP-1) based drug treatments for weight loss in adults with overweight or obesity without diabetes.Design Network meta-analysis...
021
BMJ Medicine @bmjmedicine.bsky.social · 06/09/2026
A new review by Vickram Tejwani and colleagues provides an overview of biological treatments in asthma and COPD, their clinical applications, and the role of biomarkers in guiding treatment decisions. Read the full review in BMJ Medicine: bit.ly/4gLhU63
010
BMJ Medicine @bmjmedicine.bsky.social · 04/09/2026
Trial eligibility criteria typically limit generalisability to high risk patients. So how well do SGLT2 inhibitors work in real life in people with heart failure and a preserved ejection fraction (HFpEF)? A study by Selvaganesan et al. in BMJ Medicine aimed to find out.
110
BMJ Medicine @bmjmedicine.bsky.social · 21/08/2026
Daniel Belavý and colleagues examine the efficacy of conservative (non-surgical) treatments, usual care, and no treatment for chronic radicular and non-specific back pain Read now in BMJ Medicine: bit.ly/4wuPrr3
bit.ly
Conservative treatments for chronic non-specific low back pain: time course network meta-analysis
Objective To examine the efficacy of conservative (non-surgical) treatments, usual care, and no treatment for chronic radicular and non-specific back pain.Design Time course network meta-analysis.Data...
000
BMJ Medicine @bmjmedicine.bsky.social · 19/08/2026
How can patients prepare for planned surgery? Daniel McIsaac and colleagues looks at the current prehabilitation science and practice, and explore the necessary steps to deliver effective prehabilitation before planned surgery. bit.ly/4i9hCbn
bit.ly
Prehabilitation in preparation for surgery
Prehabilitation transforms the preoperative waiting period into an opportunity for patients to actively improve their health before surgery. With surgical populations ageing and presenting with increa...
001
BMJ Medicine @bmjmedicine.bsky.social · 17/08/2026
Maximilian Siebert and colleagues evaluate the use of postmarketing requirements under the FDA Amendments Act and postmarketing commitments issued by the US FDA, for new drugs approved from 2016 to 2024. bit.ly/4qjgHas
bmjmedicine.bmj.com
Completion and outcomes of postmarketing requirements and commitments issued by the US Food and Drug Administration for new drugs, 2016-24: cross sectional evaluation of postmarketing studies
Objectives To evaluate the use of postmarketing requirements under the FDA Amendments Act (FDAAA) and postmarketing commitments issued by the US Food and Drug Administration (FDA), for new drugs appro...
000
BMJ Medicine @bmjmedicine.bsky.social · 14/08/2026
Uttara Partap and colleagues estimate the associations between gestational weight gain and maternal immediate perinatal and postpartum outcomes in low and middle income countries. Read now in BMJ Medicine: bit.ly/4x0XfC0
bit.ly
Gestational weight gain and maternal immediate perinatal and postpartum outcomes in low and middle income countries: individual participant data meta-analyses
Objective To estimate the associations between gestational weight gain and maternal immediate perinatal and postpartum outcomes by pooling data from low and middle income countries.Design Individual p...
000
BMJ Medicine @bmjmedicine.bsky.social · 10/08/2026
In their study, Carlos Sánchez-Soriano and colleagues find that one in eight mothers in England had a diagnosis of gestational diabetes between 2018-2022, and call for strategies to provide and improve care for this high risk group. bit.ly/45c7lne
000
BMJ Medicine @bmjmedicine.bsky.social · 07/08/2026
A new study by Carlos Sánchez-Soriano and colleagues quantifies the incidence of gestational diabetes mellitus in England and examines inequalities in diagnosis and adverse pregnancy outcomes. Read now in BMJ Medicine: bit.ly/4z2AOhg #MaternalHealth
000
BMJ Medicine @bmjmedicine.bsky.social · 29/07/2026
In their new study, Maximilian Siebert and colleagues evaluate the use of postmarketing requirements under the FDA Amendments Act and postmarketing commitments issued by the US FDA, for new drugs approved from 2016 to 2024. Read now in BMJ Medicine bit.ly/4yNktg6
bit.ly
Completion and outcomes of postmarketing requirements and commitments issued by the US Food and Drug Administration for new drugs, 2016-24: cross sectional evaluation of postmarketing studies
Objectives To evaluate the use of postmarketing requirements under the FDA Amendments Act (FDAAA) and postmarketing commitments issued by the US Food and Drug Administration (FDA), for new drugs appro...
000
BMJ Medicine @bmjmedicine.bsky.social · 23/07/2026
New research from Uttara Partap and colleagues estimates the associations between gestational weight gain and maternal immediate perinatal and postpartum outcomes in low and middle income countries. Read now in BMJ Medicine: bit.ly/45ncF76 #MaternalHealth
bit.ly
000
BMJ Medicine @bmjmedicine.bsky.social · 15/07/2026
Scientific progress depends on more than discovery. This editorial, published in Considerations in Medicine, makes the case for recognising replication, transparency, and methodological rigour as essential components of impactful research. Read it here: bit.ly/4fOl7mu
011
BMJ Medicine @bmjmedicine.bsky.social · 13/07/2026
How does gestational weight gain impact maternal perinatal and postpartum outcomes? Uttara Partap and colleagues estimate the associations between gestational weight gain and maternal immediate perinatal and postpartum outcomes in low and middle income countries. bit.ly/4gAC5W2
bit.ly
Gestational weight gain and maternal immediate perinatal and postpartum outcomes in low and middle income countries: individual participant data meta-analyses
Objective To estimate the associations between gestational weight gain and maternal immediate perinatal and postpartum outcomes by pooling data from low and middle income countries.Design Individual p...
101
BMJ Medicine @bmjmedicine.bsky.social · 11/07/2026
A new review by Daniel McIsaac and colleagues looks at the current prehabilitation science and practice, and explore the necessary steps to deliver effective prehabilitation before planned surgery. bit.ly/4xWuw25
000
BMJ Medicine @bmjmedicine.bsky.social · 09/07/2026
Daniel Belavý and colleagues examine the efficacy of non-surgical treatments for chronic radicular and non-specific back pain. In this study they found that while some treatments were effective for pain and function in the short term, improvements did not persist long term. bit.ly/4wmcXH0
bit.ly
Conservative treatments for chronic non-specific low back pain: time course network meta-analysis
Objective To examine the efficacy of conservative (non-surgical) treatments, usual care, and no treatment for chronic radicular and non-specific back pain.Design Time course network meta-analysis.Data...
020
BMJ Medicine @bmjmedicine.bsky.social · 06/07/2026
How effective are conservative (non-surgical) treatments for chronic non-specific low back pain? New research by Daniel Belavý and colleagues examines the efficacy of conservative treatments, usual care, and no treatment for chronic radicular and non-specific back pain. bit.ly/4gXIR8c
bit.ly
Conservative treatments for chronic non-specific low back pain: time course network meta-analysis
Objective To examine the efficacy of conservative (non-surgical) treatments, usual care, and no treatment for chronic radicular and non-specific back pain.Design Time course network meta-analysis.Data...
010
BMJ Medicine @bmjmedicine.bsky.social · 03/07/2026
Daniel McIsaac and colleagues highlights the effects of multimodal prehabilitation on improving clinical and patient centred outcomes. Combining exercise and nutrition offers the most effective route to better clinical outcomes for surgical patients. bit.ly/3Riprk1
012
BMJ Medicine @bmjmedicine.bsky.social · 30/06/2026
There’s been a lot of hype about personalised medicine and the potential of polygenic risk scores to help prevent disease. High risk individuals can be identified from genetic testing and targeted with prevention strategies. But how effective is communicating this risk to people?
110
BMJ Medicine @bmjmedicine.bsky.social · 22/06/2026
New research by Luigi Russo and colleagues finds disclosing polygenic risk scores does not result in meaningful change to patient health behaviours or outcomes. Despite promising claims, current RCT data shows limited impact on preventive measures bit.ly/4oBzxsE
bit.ly
Effects of polygenic risk score communication on short term health outcomes: systematic review and meta-analysis
Objective To summarise the evidence so far from all randomised controlled trials on the efficacy of communication of polygenic risk scores in changing health outcomes.Design Systematic review and meta...
010
BMJ Medicine @bmjmedicine.bsky.social · 20/06/2026
Scientific progress depends on more than discovery. This editorial, published in Considerations in Medicine, makes the case for recognising replication, transparency, and methodological rigour as essential components of impactful research. Read it here: bit.ly/4fOl7mu
021
BMJ Medicine @bmjmedicine.bsky.social · 16/06/2026
Does disclosing polygenic risk scores change health outcomes? New research by Luigi Russo and colleagues summarises the evidence so far from all RCTs on the efficacy of communication of polygenic risk scores in changing health outcomes. bit.ly/3SnKPVa
bmjmedicine.bmj.com
Effects of polygenic risk score communication on short term health outcomes: systematic review and meta-analysis
Objective To summarise the evidence so far from all randomised controlled trials on the efficacy of communication of polygenic risk scores in changing health outcomes.Design Systematic review and meta...
000
BMJ Medicine @bmjmedicine.bsky.social · 13/06/2026
A new review by Catrin Cox and colleagues discusses identifying and managing the coagulopathy of severe postpartum haemorrhage and reports on the new understanding of the haemostatic changes of postpartum haemorrhage Read the full review in BMJ Medicine: bit.ly/4amQQYo
bmjmedicine.bmj.com
New approaches in the haemostatic management of postpartum haemorrhage
Postpartum haemorrhage is the leading cause of maternal mortality worldwide, accounting for a substantial proportion of preventable deaths, particularly in settings with limited resources. Despite its clinical significance, understanding the haemostatic...
021
BMJ Medicine @bmjmedicine.bsky.social · 11/06/2026
Catrin Cox and colleagues examine new approaches in the haemostatic management of postpartum haemorrhage in this specialist review. bit.ly/4uyXHVU
bit.ly
New approaches in the haemostatic management of postpartum haemorrhage
Postpartum haemorrhage is the leading cause of maternal mortality worldwide, accounting for a substantial proportion of preventable deaths, particularly in settings with limited resources. Despite its clinical significance, understanding the haemostatic...
010
Reposted by BMJ Medicine
Greg Bryson @glbryson.bsky.social · 17/03/2026
Great thread on immortal time bias. Save the paper for your next journal club.
012
Reposted by BMJ Medicine
Jocalyn Clark @jocalynclark.bsky.social · 10/06/2026
The proposed new rules on federal funding are another blow to 🇺🇸 science But they will also harm international collaborations, the lifeblood of science and health 🌐 Where is the US medical leadership and outrage? My new piece @bmj_latest www.bmj.com/content/393/...
BMJ Opinion article on proposed US OMB rules
33118
BMJ Medicine @bmjmedicine.bsky.social · 05/06/2026
Laura Shannon and colleagues examine the pathogenesis of pulmonary fibrosis and link the evolving mechanistic insights to current and emerging therapeutic strategies in this review. Read now in BMJ Medicine: bit.ly/3REaoRH
bit.ly
Pulmonary fibrosis: evolving therapeutic pipeline
Current treatment for pulmonary fibrosis is limited to nintedanib and pirfenidone, which slow but do not halt or reverse the progression of the disease. These treatments are widely used globally. Emerging agents, such as nerandomilast, showed positive r...
000
BMJ Medicine @bmjmedicine.bsky.social · 03/06/2026
A new review by Laura Shannon and colleagues examines the pathogenesis of pulmonary fibrosis and links evolving mechanistic insights to current and emerging therapeutic strategies. Read now in BMJ Medicine: bit.ly/3REaoRH
bit.ly
Pulmonary fibrosis: evolving therapeutic pipeline
Current treatment for pulmonary fibrosis is limited to nintedanib and pirfenidone, which slow but do not halt or reverse the progression of the disease. These treatments are widely used globally. Emerging agents, such as nerandomilast, showed positive r...
020
BMJ Medicine @bmjmedicine.bsky.social · 01/06/2026
Delphine Mitanchez and colleagues assesses whether procalcitonin-guided decision making can safely reduce the duration of antibiotic treatment in neonatal late onset sepsis in newborns Read the full study in BMJ Medicine: bit.ly/3PILP5q
111
BMJ Medicine @bmjmedicine.bsky.social · 30/05/2026
Yan Xie and colleagues assess whether initiation of GLP-1 receptor agonists rather than sulfonylureas is associated with all cause acute pancreatitis and cause specific acute pancreatitis Read in BMJ Medicine: bit.ly/49iTWfB
bit.ly
GLP-1 receptor agonists and risk of all cause and cause specific acute pancreatitis: target trial emulation
Objectives To assess whether initiation of glucagon-like peptide-1 receptor agonists (GLP-1RAs) rather than sulfonylureas is associated with all cause acute pancreatitis and cause specific acute pancreatitis and to characterise temporal risk patterns of...
000
BMJ Medicine @bmjmedicine.bsky.social · 28/05/2026
Georgina Nakafero and colleagues examine incidence of fragility fracture, atypical femoral fracture & osteonecrosis of the jaw after bisphosphonate prescription. Read the full paper in BMJ Medicine: bit.ly/4uIFTIE
010
BMJ Medicine @bmjmedicine.bsky.social · 26/05/2026
In this study, Marc Raynaud and colleagues validate the integrative Box (iBox) prediction system for kidney allograft failure in real world settings and clinical scenarios bit.ly/4v4Oghx
000
BMJ Medicine @bmjmedicine.bsky.social · 24/05/2026
A new randomised control trial by Delphine Mitanchez and colleagues assesses whether procalcitonin-guided decision making can safely reduce the duration of antibiotic treatment in neonatal late onset sepsis Read the full study in BMJ Medicine: bit.ly/3RvkAf0
000
BMJ Medicine @bmjmedicine.bsky.social · 22/05/2026
Paul van Amstel and colleagues and colleagues compare non-operative treatment strategy with appendectomy for children with simple appendicitis, looking at complications, quality of life, and cost-effectiveness. Read the full study in BMJ Medicine: bit.ly/49FrPY1
010
BMJ Medicine @bmjmedicine.bsky.social · 20/05/2026
How can we safely reduce antibiotic exposure in newborns with late onset sepsis? Delphine Mitanchez and colleagues investigates if procalcitonin-guided decision-making can safely reduce the duration of antibiotic treatment for neonatal late onset sepsis. bit.ly/42BXRQZ
000
BMJ Medicine @bmjmedicine.bsky.social · 18/05/2026
Can non-operative treatment safely help children avoid appendectomy? Paul van Amstel and colleagues compare a non-operative strategy with surgery for simple appendicitis, examining complications, quality of life, and cost savings after one year. bit.ly/4wCoSkK
010
BMJ Medicine @bmjmedicine.bsky.social · 13/05/2026
The results from a new study by Marc Raynaud and colleagues highlight the versatility of the iBox system, a prediction model for long term risk of kidney allograft failure, and support its use for risk stratification in routine clinical practice bit.ly/4wofPUr
010
BMJ Medicine @bmjmedicine.bsky.social · 11/05/2026
Yan Xie and colleagues assess whether initiation of GLP-1 receptor agonists rather than sulfonylureas is associated with all cause acute pancreatitis and cause specific acute pancreatitis in this nationwide cohort. bit.ly/3RpLpBe
000
BMJ Medicine @bmjmedicine.bsky.social · 09/05/2026
Amira Mahmood and colleagues summarises the latest WHO treatment guidelines for pulmonary tuberculosis, including evidence to support agents and regimens, and emerging therapies. Read in BMJ Medicine: bit.ly/3ORCJ61
000
BMJ Medicine @bmjmedicine.bsky.social · 07/05/2026
Research by Georgina Nakafero and colleagues examines incidence of fragility fracture, atypical femoral fracture & osteonecrosis of the jaw after bisphosphonate prescription. Read the full paper in BMJ Medicine: bit.ly/4uzkzoL
010
BMJ Medicine @bmjmedicine.bsky.social · 01/05/2026
Yan Xie and colleagues assess whether initiation of GLP-1 receptor agonists rather than sulfonylureas is associated with all cause acute pancreatitis and cause specific acute pancreatitis in this nationwide cohort. bit.ly/4eQZbGG
bit.ly
Just a moment...
010
BMJ Medicine @bmjmedicine.bsky.social · 30/04/2026
Explore our Methods Primers Collection, where all resources in this area are conveniently organized for your reference bit.ly/45vZb9G
020
BMJ Medicine @bmjmedicine.bsky.social · 29/04/2026
A new review by Amira Mahmood and colleagues summarises the latest consolidated WHO treatment guidelines for pulmonary tuberculosis including evidence to support agents and regimens, and emerging therapies. Read the full review in BMJ Medicine: bit.ly/4ugPFl0
bit.ly
Just a moment...
010
BMJ Medicine @bmjmedicine.bsky.social · 27/04/2026
Is there association between fragility fracture and interruption of bisphosphonate prescription? New research by Georgina Nakafero and colleagues examines incidence of fragility fracture, atypical femoral fracture & osteonecrosis of the jaw after bisphosphonate prescription. bit.ly/4eLCR1f
bmjmedicine.bmj.com
Just a moment...
000
BMJ Medicine @bmjmedicine.bsky.social · 22/04/2026
Vaccine cold chains are vital but prone to weaknesses that are particularly acute in sub-Saharan Africa. Gilbert Rukundo and colleagues examine how new advances and challenges in vaccine cold chains will affect readiness to control vaccine preventable disease LMICs in Africa bit.ly/4ckcvlw
bit.ly
Just a moment...
000